Literature DB >> 23337244

STARD5 specific ligand binding: comparison with STARD1 and STARD4 subfamilies.

Danny Létourneau1, Andrée Lefebvre, Pierre Lavigne, Jean-Guy LeHoux.   

Abstract

We present herein a review of our recent results on the characterization of the binding sites of STARD1, STARD5 and STARD6 using NMR and other biophysical techniques. Whereas STARD1 and STARD6 bind cholesterol, no cholesterol binding could be detected for STARD5. However, titration of STARD5 with cholic acid and chenodeoxycholic acid led to specific binding. Using perturbation of the (1)H-(15)N-HSQC spectra and the sequence specific NMR assignments, we identified the amino acids in contact with those ligands. The most perturbed residues in presence of ligands are lining the internal cavity of the protein. Interestingly, these residues are not conserved in STARD1 and STARD6 and could therefore be key structural determinants of the specificity of START domains toward their ligands. We highlight three tissues expressing STARD5 that are affected by bile acids.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23337244     DOI: 10.1016/j.mce.2013.01.004

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  3 in total

Review 1.  Mitochondrial cholesterol: mechanisms of import and effects on mitochondrial function.

Authors:  Laura A Martin; Barry E Kennedy; Barbara Karten
Journal:  J Bioenerg Biomembr       Date:  2014-11-26       Impact factor: 2.945

2.  STARD6 is expressed in steroidogenic cells of the ovary and can enhance de novo steroidogenesis.

Authors:  Holly A LaVoie; Nicole E Whitfield; Bo Shi; Steven R King; Himangshu S Bose; Yvonne Y Hui
Journal:  Exp Biol Med (Maywood)       Date:  2014-03-04

3.  STARD6 on steroids: solution structure, multiple timescale backbone dynamics and ligand binding mechanism.

Authors:  Danny Létourneau; Mikaël Bédard; Jérôme Cabana; Andrée Lefebvre; Jean-Guy LeHoux; Pierre Lavigne
Journal:  Sci Rep       Date:  2016-06-24       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.